Michelle Stansbury, vice president of innovation and IT applications at Houston Methodist, joins the Houston Innovators Podcast. Photo courtesy of Houston Methodist

It might surprise most to know that Houston Methodist doesn't have an innovation department within their hospital system — at least not one set up as you'd imagine, with a team specifically dedicated to innovation. Instead, Houston Methodist's Digital Innovation Obsessed People, or DIOP, consists of leaders across departments.

Michelle Stansbury is one of those leaders. As vice president of innovation and IT applications at Houston Methodist, she oversees the system's IT department and serves as a leader within its innovation efforts. This includes the Center for Innovation Technology Hub — which opened in 2020 in the Texas Medical Center location and opened its Ion outpost last week.

Stansbury explains on the Houston Innovators Podcast how effective this distribution of innovation responsibilities has been for Houston Methodist. With everyone having a seat at the table — operations knows the biggest problems that need solutions, IT knows how to deploy technology, etc. — implementation of new innovations has been sped up.

"If we partner together, we should be able to succeed fast or fail fast," she says on the show. "We've been able to find a solution, pilot it, and, if it works well, roll it out at a speed that most other organizations have not been able to do. It's been highly successful for us."

The newest way Houston Methodist is mixing up how it brings in innovative solutions to its team and patients is by taking its team outside of the Texas Medical Center and its hospitals in general. Now, Houston Methodist has a permanent tech hub in the Ion, owned and operated by Rice Management Company, on the lower level of the building, completely open to any of the Ion's visitors.

"We've always had a great partnership with Rice. This almost felt like an extension with Houston Methodist and our Rice collaboration with the Ion," Stansbury says. "Our main goals have been how can we utilize the talent that's housed out of that facility."

She explains that the new hub is an extension of the original hub in the TMC hospital, and that innovators who are interested in collaborating with Houston Methodist — especially those with solutions applicable to health care — can visit the Ion hub as an entry point.

Both hub locations showcase pilot technology Houston Methodist is working on, and that technology will then get deployed out into its hospital locations — and especially its Cypress hospital, which is being billed as being the "smart hospital of the future." The construction is underway and expected to deliver in 2025.

Stansbury shares more about this ninth location for Houston Methodist as well as more details on the new tech hub on the podcast. Listen to the interview here — or wherever you stream your podcasts — and subscribe for weekly episodes.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”